• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Biotherapeutics: Recent Developments using Chemical and Molecular Biology

Biotherapeutics: Recent Developments using Chemical and Molecular Biology

9781849736015
1 007,94 zł
907,14 zł Zniżka 100,80 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 907,14 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
This book illustrates the successful partnership of chemistry and biology to advance successful biotherapeutic modalities. Molecular design to create function is common to both chemical and molecular biology, and this text highlights recent developments from these disciplines that have delivered drugs, clinical candidates or significantly advanced biotherapeutic approaches. Biotherapeutics are often considered to be beyond the reach of the medicinal chemist, but this book demonstrates that chemistry has an essential role in the future success of this area, by explaining and describing the chemical biology technologies that underpin specific therapeutic advances and demonstrating the unique value of molecular design and understanding. Covering topics such as selective protein modification, immunopharmacotherapy, chemically programmed vaccinations, nanobodies and antibodies, this book provides essential reading for medicinal and pharmaceutical chemists working in both industry and academia.
Szczegóły produktu
77315
9781849736015
9781849736015

Opis

Rok wydania
2013
Numer wydania
1
Oprawa
twarda
Liczba stron
336
Wymiary (mm)
156.00 x 234.00
Waga (g)
669
  • Synthetic Vaccines; Peptide Epitope Expressions; Carbohydrate vaccines; MicroRNA; Recent Advances in Antibody-Directed Conjugates; Selective Protein Modifications; Immunopharmacotherapy; Technologies being applied to B cell repertoire screening for Antibodies against Infectious Pathogens; Cyclotides and Cysteine-Knot Peptides; Phage Expression of Chemically-Constrained Cyclic Peptides; Nanobodies
Komentarze (0)